Literature DB >> 21536634

Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.

C B Josephson1, J-P Leach, R Duncan, R C Roberts, C E Counsell, R Al-Shahi Salman.   

Abstract

OBJECTIVES: To determine the risk of epileptic seizures due to a brain arteriovenous malformation (AVM) or cavernous malformation (CM).
METHODS: In a prospective population-based study of new diagnoses of AVMs (n = 229) or CMs (n = 139) in adults in Scotland in 1999-2003, we used annual medical records surveillance, general practitioner follow-up, and patient questionnaires to quantify the risk of seizures between clinical presentation and AVM/CM treatment, last follow-up, or death.
RESULTS: The 5-year risk of first-ever seizure after presentation was higher for AVMs presenting with intracranial hemorrhage or focal neurologic deficit (ICH/FND: n = 119; 23%, 95% confidence interval [CI] 9%-37%) than for incidental AVMs (n = 40; 8%, 95% CI 0%-20%), CMs presenting with ICH/FND (n = 38; 6%, 95% CI 0%-14%), or incidental CMs (n = 57; 4%, 95% CI 0%-10%). For adults who had never experienced ICH/FND, the 5-year risk of epilepsy after first-ever seizure was higher for CMs (n = 23; 94%, 95% CI 84%-100%) than AVMs (n = 37; 58%, 95% CI 40%-76%; p = 0.02). Among adults who never experienced ICH/FND and presented with or developed epilepsy, there was no difference in the proportions achieving 2-year seizure freedom over 5 years between AVMs (n = 43; 45%, 95% CI 20%-70%) and CMs (n = 35; 47%, 95% CI 27%-67%).
CONCLUSIONS: AVM-related ICH confers a significantly higher risk of a first-ever seizure compared to CMs or incidental AVMs. Adults with a CM have a high risk of epilepsy after a first-ever seizure but achieve seizure freedom as frequently as those with epilepsy due to an AVM.

Entities:  

Mesh:

Year:  2011        PMID: 21536634      PMCID: PMC3100127          DOI: 10.1212/WNL.0b013e3182190f37

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

2.  Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992.

Authors:  R D Brown; D O Wiebers; J C Torner; W M O'Fallon
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

3.  Scottish Intracranial Vascular Malformation Study (SIVMS): evaluation of methods, ICD-10 coding, and potential sources of bias in a prospective, population-based cohort.

Authors:  Rustam Al-Shahi; Jo J Bhattacharya; David G Currie; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow
Journal:  Stroke       Date:  2003-04-17       Impact factor: 7.914

4.  The natural history of cavernous malformations: a prospective study of 68 patients

Authors: 
Journal:  Neurosurgery       Date:  1999-06       Impact factor: 4.654

5.  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Authors:  Rodney A Gabriel; Helen Kim; Stephen Sidney; Charles E McCulloch; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Jonathan G Zaroff; William L Young
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

6.  Electrographic seizures and periodic discharges after intracerebral hemorrhage.

Authors:  J Claassen; N Jetté; F Chum; R Green; M Schmidt; H Choi; J Jirsch; J A Frontera; E Sander Connolly; R G Emerson; S A Mayer; L J Hirsch
Journal:  Neurology       Date:  2007-09-25       Impact factor: 9.910

Review 7.  Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.

Authors:  Rustam Al-Shahi Salman; Michel J Berg; Leslie Morrison; Issam A Awad
Journal:  Stroke       Date:  2008-10-30       Impact factor: 7.914

8.  Arteriovenous malformations of the brain: natural history in unoperated patients.

Authors:  P M Crawford; C R West; D W Chadwick; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

9.  Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes.

Authors:  Brian L Hoh; Paul H Chapman; Jay S Loeffler; Bob S Carter; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

Review 10.  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Zoe Morris; William N Whiteley; W T Longstreth; Frank Weber; Yi-Chung Lee; Yoshito Tsushima; Hannah Alphs; Susanne C Ladd; Charles Warlow; Joanna M Wardlaw; Rustam Al-Shahi Salman
Journal:  BMJ       Date:  2009-08-17
View more
  29 in total

1.  Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients.

Authors:  Dario J Englot; William L Young; Seunggu J Han; Charles E McCulloch; Edward F Chang; Michael T Lawton
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

Review 2.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

Review 3.  Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies.

Authors:  Shervin Taslimi; Amirhossein Modabbernia; Sepideh Amin-Hanjani; Fred G Barker; R Loch Macdonald
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

Review 4.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

Review 5.  Can developmental venous anomalies cause seizures?

Authors:  Claire Dussaule; Pascal Masnou; Ghaïdaa Nasser; Frédérique Archambaud; Cécile Cauquil-Michon; Jean-Paul Gagnepain; Viviane Bouilleret; Christian Denier
Journal:  J Neurol       Date:  2017-03-17       Impact factor: 4.849

6.  Seizure control following treatment of brain arteriovenous malformations in pediatric patients.

Authors:  Xiangke Ma; Xianzeng Tong; Jun Wu; Yong Cao; Shuo Wang
Journal:  Childs Nerv Syst       Date:  2016-09-01       Impact factor: 1.475

Review 7.  Clinical Management of Cavernous Malformations.

Authors:  Kelly D Flemming
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

8.  Seizure risk with AVM treatment or conservative management: prospective, population-based study.

Authors:  Colin B Josephson; Jo J Bhattacharya; Carl E Counsell; Vakis Papanastassiou; Vaughn Ritchie; Richard Roberts; Robin Sellar; Charles P Warlow; Rustam Al-Shahi Salman
Journal:  Neurology       Date:  2012-07-03       Impact factor: 9.910

Review 9.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

Review 10.  Medical vs. invasive therapy in AVM-related epilepsy: Systematic review and meta-analysis.

Authors:  Colin B Josephson; Khara Sauro; Samuel Wiebe; Fiona Clement; Nathalie Jette
Journal:  Neurology       Date:  2015-12-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.